Abciximab (Abci) and eptifibatide (Epti) are antiaggregate drugs which may reduce thrombotic complications inacute coronary syndromes. The aim of this work was the investigation of the interaction between the phospholipid-GPIIb/IIIa glycoprotein complex ...
Ewa Gorodkiewicz +2 more
doaj
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes [PDF]
The PURSUIT trial investigators
openalex +1 more source
EPH57 The Market Dynamics of GP IIb/IIIa Inhibitors in Germany: A Closer Look at Eptifibatide and Aggrastat [PDF]
S. Wahler +2 more
openalex +1 more source
A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion In Patients Undergoing Primary Percutaneous Coronary Intervention For ST-Elevation Myocardial Infarction [PDF]
Mehdi Mousavi +4 more
openalex +1 more source
E-008 Safety and efficacy of eptifibatide in acute ischemic stroke requiring extracranial carotid artery stenting [PDF]
Michael J. Waters +4 more
openalex +1 more source
Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia [PDF]
Andreas Greinacher +7 more
openalex +1 more source
Eptifibatide and 7E3, but Not Tirofiban, Inhibit α v β 3 Integrin–Mediated Binding of Smooth Muscle Cells to Thrombospondin and Prothrombin [PDF]
Manjiri Lele +3 more
openalex +1 more source
Objective To explore the efficacy and safety of endovascular treatment (EVT) combined with eptifibatide in the treatment of acute ischemic stroke. Methods This study enrolled the 102 acute ischemic stroke patients at 15 centers in China received EVT ...
HU Xiao⁃yan +5 more
doaj +1 more source
Comparative efficacy of eptifibatide and abciximab in primary angioplasty study
Rohan Jayasinghe1 Matias Yudi1 Sanjay Jayasinghe21Cardiology Department, Gold Coast Hospital, Griffith University, Queensland, Australia; 2Centre for Immunisation Research, Sydney, AustraliaBackground: Primary percutaneous intervention is the safest and ...
Rohan Jayasinghe +2 more
doaj
Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS [PDF]
Connie N. Hess +10 more
openalex +1 more source

